期刊文献+

吸毒对肺结核患者病情的影响 被引量:3

Influence of Drug Taking on Seriousness of Pulmonary Tuberculosis
下载PDF
导出
摘要 目的 探讨吸毒对肺结核患者病情的影响。 方法  对比吸毒和非吸毒肺结核患者治疗前后的临床症状、痰菌情况及胸片的改变。 结果  治疗前吸毒者患肺结核的临床症状重 ,痰菌阳性率、空洞形成率和病变范围与对照组比较均明显升高 ;治疗后肺结核临床症状改善率、痰菌阴转率、胸片病灶吸收好转率及空洞缩小率则明显降低 ,两者比较差异有显著性 (P <0 .0 1)。 Objective To probe into the influence of drug taki ng on the seriousness of pulmonary tuberculosis.Methods To compar e the clinical symptoms,sputum examination and chest X-ray before and after trea tment between drug taking group and non-drug taking group.Results There were significantly increased the severity of clinical symptoms,the sputum positive rate,rate of cavitation, and the scope of pathological changes were si gnificantly increased compared with control groups before treatment.The improvem ent of clinical symtoms,the sputum negative convertion rate,scope of pathologica l improvement ,cavity reduce rate were signigicantly decreased after treatment.Th e difference between the two groups was significant(P<0.01).Conclu sion Drug taking may aggravate the severity of pulmonary tuberculosis.
作者 郭新枝 陈裕
出处 《医药论坛杂志》 2003年第20期11-12,共2页 Journal of Medical Forum
关键词 吸毒 肺结核 病情 痰菌阳性率 空洞形成率 drug taking pulmonary tuberculosis.
  • 相关文献

参考文献7

二级参考文献18

共引文献55

同被引文献23

  • 1贾宝芸,徐文丽.207例吸毒患者戒毒的护理探讨[J].宁夏医学杂志,1995,17(4):252-253. 被引量:1
  • 2Global tuberculosis control: epidemiology, strategy, financing: WHO reoort 2009.
  • 3~lobal tuberculosis control : WHO report 2010.
  • 4Markowitz N, Hansen NI, Wilcosky TC, et al. Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative person. Pulmonary Complication of HIV Infection Study Group. Ann Intern Med, 1993, 119 : 185-193.
  • 5Friedman H, Newton C, Klein TW. Microbial infections, immunomodulation, and drugs of abuse. Clin Micmbiol Rev, 2003, 16:209-219.
  • 6Reichman LB, Felton CP, Edsall JR. Drug dependence, a possible new risk factor for tuberculosis disease. Arch Intern Med, 1979, 139:337-339.
  • 7Alpert PL, Munsiff SS, Gourevitch MN, et al. A prospective study of tuberculosis and human immunodeficiency virus infection: clinical manifestations and factors associated with survival. Clin Infect Dis, 1997,24:661-668.
  • 8Use of QuantiFERON -TB Gold In Tube assay to estimate the prevalence of M. Tuberculosis infection among injection drug user at risk for HIV in Tijuana,Mexico.
  • 9Lalvani A. Diagnosing tuberculosis infection in the 21st century. New tools to tackle an old enemy. Chest,2007,131:1898-1906.
  • 10Towards universal access to diagnosis and treatment of multidrug- resistant and extensively drug-resistant tuberculosis by 2015:WHO progress report 2011.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部